KARA PROBST: Open Payments
NPI 1457923849 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,122 in 210 payments from 23 companies in 2025. Trend: 2023 $3,943 · 2024 $2,304 · 2025 $4,122
Food & beverage: $3,912Education: $209
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 34 | $575 |
| Neurocrine BioSciences, Inc. | 19 | $439 |
| ABBVIE INC. | 21 | $388 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $381 |
| Teva Pharmaceuticals USA, Inc. | 16 | $365 |
| Otsuka America Pharmaceutical, Inc. | 24 | $338 |
| Lundbeck LLC | 16 | $316 |
| Vanda Pharmaceuticals Inc. | 12 | $291 |
| Axsome Therapeutics, Inc. | 12 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $140 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, ARISTADA, REXULTI, ABILIFY MAINTENA, FANAPT, Auvelity.
Industry payments across NC — which companies pay providers there.
